Gallium 68 PET Scans – Into the Unknown

Gallium 68 PET Scans – Into the Unknown

Inspiration, Living with Neuroendocrine Cancer, Survivorship, Technical NETs
OPINION Cancer is a growth industry ...literally! More people are being diagnosed than ever before. Fortunately, more people are surviving than ever before. This is against a backdrop of better awareness, better screening in the big population cancers, and to a certain extent better diagnostic tools, all of which is leading to earlier diagnosis. So how does this affect Neuroendocrine Cancer? According to the latest SEER database figures for Neuroendocrine Cancer, one reason for the 7 fold increase in incidence rates since the 1970s is all of those things above including better diagnostics. This has led to a revised set of epidemiological information in many countries that have made the effort to accurately update their cancer registries and there are consistent reports of incidence rates way beyond the recognised rare…
Read More

PRRT and Chemo combination therapy – on trial

Awareness, Technical NETs, Treatment
  I recently posted an 'Onc Live' video series about Neuroendocrine Tumour (NET) treatments and the final episode talked about combination treatments i.e. where more than one treatment is administered simultaneously.  An interesting and exciting area to watch for the treatment of NET patients. Thought you'd be interested in a potential new treatment being developed in Australia.  The use of PRRT and chemo (in particular CAPTEM) or 'PRCRT'. The attached video is a presentation by Dr Michael Hofman who I see regularly on twitter posting some very interesting stuff. He's a great advocate for NET patients. The video will explain in some detail how the treatment is thought to work together. Additionally, it also provides excellent PRRT information. Dr Hofman has some really interesting things to say.  20 minutes -…
Read More